Osmium-Catalyzed Olefin Dihydroxylation and Aminohydroxylation
FULL PAPERS
by chiral HPLC and the absolute configuration was estab-
lished by comparing optical rotation with authentic samples.
(S)-12, 43% ee (Chiralcel-OG, i-PrOH/hexane, 30:70,
1.5 mLminÀ1) and (R)-13, 55% ee (Chiralcel-AS, i-PrOH/
hexane, 30:70, 1.5 mLminÀ1).
[2] E. Herranz, K. B. Sharpless, J. Org. Chem. 1978, 43,
2544.
[3] a) G. Li, H.-T. Chang, K. B. Sharpless, Angew. Chem.
1996, 108, 449; Angew. Chem. Int. Ed. Engl. 1996, 35,
451; b) G. Li, H. H. Angert, K. B. Sharpless, Angew.
Chem. 1996, 108, 2995; Angew. Chem. Int. Ed. Engl.
1996, 35, 2813; c) H. C. Kolb, K. B. Sharpless, Transi-
tion Metals for Fine Chemicals and Organic Synthesis,
Vol. 2, (Eds.: M. Beller, C. Bolm), Wiley–VCH, Wein-
heim, 1998, pp. 243–260; d) D. Nilov, O. Reiser, Adv.
Synth. Catal. 2002, 344, 1169.
[4] H.-T. Chang, PhD thesis, The Scripps Research Insti-
tute (USA), Diss. Abstr. Int., B 1997, 57(12), 7528.
[5] H. C. Kolb, M. S. VanNieuwenhze, K. B. Sharpless,
Chem. Rev. 1994, 94, 2483.
[6] J. S. M. Wai, I. Markꢁ, J. S. Svendsen, M. G. Finn, E. N.
Jacobsen, K. B. Sharpless, J. Am. Chem. Soc. 1989, 111,
1123.
[7] P. Dupau, R. Epple, A. A. Thomas, V. V. Fokin, K. B.
Sharpless, Adv. Synth. Catal. 2002, 344, 421.
[8] a) A. E. Rubin, K. B. Sharpless, Angew. Chem. 1997,
109, 2751; Angew. Chem. Int. Ed. Engl. 1997, 36, 2637;
b) W. Pringle, K. B. Sharpless, Tetrahedron Lett. 1999,
40, 5151.
X-Ray Crystallographic Study
The synthesis and X-ray crystallographic study of complex
V can be found in the Supporting Information. Crystallo-
graphic data (excluding structure factors) for the struc-
ture(s) reported in this paper have been deposited with the
Cambridge Crystallographic Data Centre as supplementary
publication no. CCDC-267259. Copies of the data can be ob-
tained free of charge on application to CCDC, 12 Union
Road, Cambridge CB2 1EZ, UK [Fax: int. code + 44-
(1223)336–033; E-mail: deposit@ccdc.cam.ac.uk].
Acknowledgements
The authors are grateful to Prof. K. B. Sharpless for encour-
agement and advice. Financial support from the National In-
stitute of General Medical Sciences, National Institutes of
Health (GM 28384), the Skaggs Institute for Chemical Biol-
ogy, and Pfizer, Inc is gratefully acknowledged. P.W. is a
Skaggs predoctoral fellow.
[9] D. J. Berrisford, C. Bolm, K. B. Sharpless, Angew.
Chem. 1995, 107, 115; Angew. Chem. Int. Ed. Engl.
1995, 34, 1059.
[10] V. V. Fokin, K. B. Sharpless, Angew. Chem. 2001, 113,
3563; Angew. Chem. Int. Ed. 2001, 40, 3455.
[11] M. A. Andersson, R. Epple, V. V. Fokin, K. B. Sharp-
less, Angew. Chem. 2002, 114, 490; Angew. Chem. Int.
Ed. 2002, 41, 472.
References
[12] V. Van Rheenen, R. C. Kelly, P. Y. Cha Tetrahedron
Lett. 1976, 1973.
[1] K. B. Sharpless, D. W. Patrick, L. K. Truesdale, S. A.
Biller, J. Am. Chem. Soc. 1975, 97, 2305.
Adv. Synth. Catal. 2006, 348, 1079 – 1085
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1085